Unbounce, a leading conversion intelligence platform, announced the acquisition of LeadsRx, a marketing analytics SaaS platform that makes it easier for marketers and agencies to measure the performance of their marketing channels. Founded in 2015 in Portland, Oregon, LeadsRx helps marketers understand the value of each customer touchpoint across digital, radio, TV, podcasts, streaming services, and other advertising channels, allowing them to better optimize their conversion paths, ad spend and ROI. This acquisition positions Unbounce to be able to bring the power of marketing attribution to its small and midsize business customers.
Since its inception, LeadsRx has helped marketers optimize billions of dollars in marketing spend, collect anonymous customer data from 2.5 billion customer touchpoints, and help them make faster and more informed decisions. Today, LeadsRx serves more than 5,000 global and local brands and agencies ranging from iHeartMedia and Casper to Cumulus Media, Diray Media, and Rakuten Advertising.
LeadsRx is deeply committed to consumer data privacy. The company works off its proprietary technology that collects first-party data only. Unlike marketing attribution platforms of its kind, LeadsRx doesn’t rely on third-party cookies but instead develops private identity graphs for each of its clients.
“Unbounce and LeadsRx share a vision for the future of marketing that machines and marketers can work better together to produce the best results possible,” said AJ Brown, CEO, and co-founder of LeadsRx. “We’re bringing together some of the most creative and inventive engineers, marketing and customer services professionals — I’m excited for what the future holds and the innovative products we will be able to offer companies and agencies around the world.”
Together, these two marketing technology powerhouses will unlock new opportunities to help marketers and businesses grow smarter and faster. Brown will remain CEO of LeadsRx while reporting to Bochicchio but otherwise the 21-person LeadsRx team will continue to operate independently. While Unbounce plans on bringing the value of marketing attribution to its conversion intelligence platform, LeadsRx and Unbounce will remain standalone platforms until further assessment takes place.